ATE315544T1 - Sertralin hydrochlorid form v - Google Patents

Sertralin hydrochlorid form v

Info

Publication number: ATE315544T1
Authority: AT; Austria
Prior art keywords: sertraline hydrochloride; sertraline; produced; hydrochloride; filtration
Prior art date: 1998-11-27

Application number

AT99959091T

Other languages

English (en)

Inventor

Eduard Schwartz

Tamar Nidam

Anita Liberman

Marioara Mendelovici

Jehudit Aronhime

Claude Singer

Evgeni Valdman

Original Assignee

Teva Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-27

Filing date

1999-11-24

Publication date

2006-02-15

1999-11-24 Application filed by Teva Pharma filed Critical Teva Pharma

2006-02-15 Application granted granted Critical

2006-02-15 Publication of ATE315544T1 publication Critical patent/ATE315544T1/de

Links

GLQPTZAAUROJMO-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)benzaldehyde Chemical group C1=C(OC)C(OC)=CC=C1C1=CC=C(C=O)C=C1 GLQPTZAAUROJMO-UHFFFAOYSA-N 0.000 title abstract 12
229960003660 sertraline hydrochloride Drugs 0.000 abstract 7
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
238000001914 filtration Methods 0.000 abstract 3
229960002073 sertraline Drugs 0.000 abstract 3
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 abstract 3
238000010438 heat treatment Methods 0.000 abstract 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
235000019445 benzyl alcohol Nutrition 0.000 abstract 1
238000002425 crystallisation Methods 0.000 abstract 1
230000008025 crystallization Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
230000020477 pH reduction Effects 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99959091T 1998-11-27 1999-11-24 Sertralin hydrochlorid form v ATE315544T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US11011398P	1998-11-27	1998-11-27
US12517299P	1999-03-19	1999-03-19
US13311799P	1999-05-07	1999-05-07
US14788899P	1999-08-09	1999-08-09

Publications (1)

Publication Number	Publication Date
ATE315544T1 true ATE315544T1 (de)	2006-02-15

Family

ID=27493729

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99959091T ATE315544T1 (de)	1998-11-27	1999-11-24	Sertralin hydrochlorid form v

Country Status (9)

Country	Link
EP (1)	EP1133459B1 (de)
JP (1)	JP2002531427A (de)
AT (1)	ATE315544T1 (de)
AU (1)	AU1633600A (de)
DE (1)	DE69929462T2 (de)
ES (1)	ES2255320T3 (de)
HK (1)	HK1040979A1 (de)
IL (1)	IL143311A0 (de)
WO (1)	WO2000032551A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6500987B1 (en) *	1998-11-27	2002-12-31	Teva Pharmaceutical Industries Ltd.	Sertraline hydrochloride polymorphs
US7442838B2 (en)	1999-10-29	2008-10-28	Ciba Specialty Chemicals Corp.	Polymorphic forms of sertraline hydrochloride
TWI260315B (en)	1999-10-29	2006-08-21	Ciba Sc Holding Ag	Polymorphic forms of sertraline hydrochloride
PL356452A1 (en) *	1999-12-21	2004-06-28	Teva Pharmaceutical Industries Ltd.	Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
EP1772144A3 (de) *	1999-12-21	2007-08-15	Teva Pharmaceutical Industries Ltd	Neue Sertralinhydrochlorid Polymorphe, Verfahren zur Herstellung und zur Verwendung und diese enthaltende Zusammensetzungen
IN189886B (de) *	2000-03-29	2003-05-03	Sun Pharmaceutical Ind Ltd
IN192343B (de) *	2000-05-26	2004-04-10	Ranbaxy Lab Ltd
WO2002096859A1 (en) *	2001-05-31	2002-12-05	Orion Corporation Fermion	Process for preparing sertraline hydrochloride polymorphic form ii
WO2003093217A1 (en) *	2002-04-29	2003-11-13	Teva Pharmaceutical Industries Ltd.	Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
AU2003274608A1 (en) *	2002-11-07	2004-06-07	Sunil Sadanand Nadkarni	Process for preparation of polymorphic form of sertraline hydrochloride
WO2005000786A1 (en) *	2003-05-23	2005-01-06	Transform Pharmaceuticals, Inc.	Sertraline compositions
US8980323B2 (en)	2006-08-29	2015-03-17	Fujifilm Corporation	Hydrophilic matrix containing poorly water-soluble compound and method for producing the same
MY180626A (en)	2013-11-15	2020-12-03	Akebia Therapeutics Inc	Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) *	1991-03-06	1992-01-21	Pfizer Inc.	Process for recycling amine isomer
GB9114947D0 (en) *	1991-07-11	1991-08-28	Pfizer Ltd	Process for preparing sertraline
US5248699A (en) *	1992-08-13	1993-09-28	Pfizer Inc.	Sertraline polymorph
US5734083A (en) *	1996-05-17	1998-03-31	Torcan Chemical Ltd.	Sertraline polymorph
JP2000026378A (ja) *	1998-07-03	2000-01-25	Sumika Fine Chemicals Co Ltd	塩酸セルトラリンの製法
TWI260315B (en) *	1999-10-29	2006-08-21	Ciba Sc Holding Ag	Polymorphic forms of sertraline hydrochloride

1999
- 1999-11-24 JP JP2000585193A patent/JP2002531427A/ja active Pending
- 1999-11-24 AT AT99959091T patent/ATE315544T1/de not_active IP Right Cessation
- 1999-11-24 AU AU16336/00A patent/AU1633600A/en not_active Abandoned
- 1999-11-24 WO PCT/US1999/027881 patent/WO2000032551A1/en not_active Ceased
- 1999-11-24 DE DE69929462T patent/DE69929462T2/de not_active Expired - Fee Related
- 1999-11-24 HK HK02102021.7A patent/HK1040979A1/zh unknown
- 1999-11-24 IL IL14331199A patent/IL143311A0/xx unknown
- 1999-11-24 EP EP99959091A patent/EP1133459B1/de not_active Expired - Lifetime
- 1999-11-24 ES ES99959091T patent/ES2255320T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2255320T3 (es)	2006-06-16
WO2000032551A1 (en)	2000-06-08
IL143311A0 (en)	2002-04-21
EP1133459B1 (de)	2006-01-11
EP1133459A4 (de)	2004-09-29
AU1633600A (en)	2000-06-19
DE69929462D1 (de)	2006-04-06
JP2002531427A (ja)	2002-09-24
WO2000032551A9 (en)	2001-07-19
DE69929462T2 (de)	2006-09-07
EP1133459A1 (de)	2001-09-19
HK1040979A1 (zh)	2002-06-28

Similar Documents

Publication	Publication Date	Title
IS7308A (is)	2004-06-11	Nýr sertralínhýdróklóríðfjölgervingur og efnablanda sem inniheldur hann, nýjar aðferðir til að framleiða sertralínhýdróklóríðfjölgervinga og myndlausform
DE69929462D1 (de)	2006-04-06	Sertralin hydrochlorid form v
NO983970D0 (no)	1998-08-28	Tricykliske forbindelser, deres fremstilling og anvendelse
DE60040406D1 (de)	2008-11-13	Verfahren zur Herstellung der polymorphen Form II von Sertralin Hydrochlorid
DE69924467D1 (de)	2005-05-04	Verfahren zur herstellung von donepezilderivaten
ES2170732A1 (es)	2002-08-01	Procedimiento para preparar citalopram purificado
SI1781683T1 (sl)	2012-06-29	Postopek za pripravo 17-vinil-triflatov kot intermediatov
DE60234629D1 (de)	2010-01-14	Formoteroltartrat verfahren und polymorph
EA200400491A1 (ru)	2004-12-30	Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции
MY133531A (en)	2007-11-30	Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
BR0209901A (pt)	2004-07-13	Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
ATE407111T1 (de)	2008-09-15	Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards
EA200200939A1 (ru)	2003-02-27	Способ получения циталопрама
EA200001184A1 (ru)	2001-04-23	Фенилсульфонамидфенилэтиламины, полезные в качестве допаминовых рецепторов
Spychała	1997	A facile preparation of N2-arylisocytosines
EA200501527A1 (ru)	2006-02-24	Способ получения полиморфа малеата розиглитазона
DE602005026827D1 (de)	2011-04-21	Verfahren zur herstellung von isoindolderivaten
YU51599A (sh)	2001-03-07	POSTUPAK I INTERMEDIJERI ZA β3-ADRENERGIČNI RECEPTORSKI AGONIST
UY26111A1 (es)	2000-12-29	Derivados de ciclobuten-3, 4-diona, su preparación y su aplicación en terapéutica
EP1302459A4 (de)	2004-03-10	Verfahren zur herstellung von annelierten pyrrolen
CA2377233A1 (en)	2001-01-04	Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
DE602004027401D1 (de)	2010-07-08	Verfahren zur herstellung von polymorphen von sertralin hydrochlorid
DE60323052D1 (de)	2008-10-02	Zwei gonadotropin-freisetzende hormone und methode zur isolierung
DE68914211D1 (de)	1994-05-05	Verfahren zur Herstellung von Zwischenprodukten in der Synthese von Diltiazem.
CY1116177T1 (el)	2017-02-08	Μεθοδος για την παρασκευη 17-βινυλο-τριφλικων ως ενδιαμεσα

Legal Events

Date	Code	Title	Description
2006-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties